enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Novo Nordisk to discontinue Levemir insulin in U.S. market - AOL

   www.aol.com/news/novo-nordisk-discontinue...

   The announcement comes eight months after Novo said it would cut U.S. list prices for several of its insulin products next year, including a 65% reduction in the list price of Levemir, in response ...

3. Patients push back against Novo Nordisk move to scrap an ...

   www.aol.com/news/patients-push-back-against-novo...

   Novo reported U.S. Levemir sales of 1.3 billion Danish crowns ($185 million) in 2023, less than 10% of sales in 2016, when Novo launched the higher-priced Tresiba as a successor product.

4. Senate panel questions Novo Nordisk CEO over decision to ...

   www.aol.com/news/senate-panel-questions-novo...

   Novo Nordisk's decision has been criticized by some patients with Type 1 diabetes who prefer Levemir over other long-acting "basal" insulins such as Sanofi's Lantus and Novo Nordisk's Tresiba.

5. Insulin detemir - Wikipedia

   en.wikipedia.org/wiki/Insulin_detemir

   Insulin detemir, sold under the brand name Levemir among others, is a long-acting modified form of medical insulin used to treat both type 1 and type 2 diabetes. [6] It is used by injection under the skin . [ 6 ]

6. Novo Nordisk - Wikipedia

   en.wikipedia.org/wiki/Novo_Nordisk

   Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark [3] with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting ...

7. Novo Holdings A/S - Wikipedia

   en.wikipedia.org/wiki/Novo_Holdings_A/S

   Novo Holdings A/S (formerly Novo A/S) [1] is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation 's assets, which in 2023 was worth almost DKK 1,114 billion [ 2 ] [ 3 ] [ 4 ] Danish Kroner (approximately US$163 billion).

8. News, Politics, Sports, Mail & Latest Headlines - AOL.com

   homepage.aol.com/news

   Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL

9. Novo Nordisk faces scrutiny on Capitol Hill for pulling ...

   www.aol.com/news/novo-nordisk-faces-scrutiny...

   In April, the lawmakers wrote to the company expressing alarm at its decision, announced in November, that it would permanently discontinue Levemir by the end of 2024.